SECIntel
Float & OS567,699 / 579,218
Cash/Shr$7.30
Market Cap & EV—
Short Interest—
Cash$4.23 M
Est. Cash Today$24.13 M
Off AbilityMedium
Off FreqHigh
DilutionLow
Cash NeedLow
Overall Offering RiskHigh
Warrant Exercise RiskHigh
Nasdaq ComplianceLow

Shares Outstanding History

Cash Position

Cash Position

The company has 63.5 months of cash left based on the quarterly cash burn of $-1.14 M and estimated current cash of $24.13 M.

Commentary on Financial Condition

“Net cash used in operating activities was $4,621,892, $4,563,576, and $6,396,922 for the years ended March 31, 2026, 2025, and 2024, respectively. The increase in cash used for operations from the year ended March 31, 2025 to March 31, 2026 was mainly due to timing differences of stock-based compensation, prepaid expenses, VAT receivable and accounts payable year over year and decreased losses as the Company decreased general and administrative expenses during the years ended March 31, 2026 and 2025 as discussed above in Results of Operations. The decrease in cash used for operations from the year ended March 2024 to the year ended March 31, 2025 was mainly due to timing differences of prepaid expenses, VAT receivable and accounts payable year over year and decreased losses as the Company decreased general and administrative expenses during the years ended March 31, 2025 and 2024. Net ca” (from July 2026 filing’s Liquidity and Capital Resources) Filed At: 2026-07-03

Recent Filings
424B3Form 424B32026-09-09
6-KForm 6-K2026-09-04
424B5Form 424B52026-09-04
EFFECTForm EFFECT2026-09-04
F-3/AForm F-3/A2026-09-02
6-KForm 6-K2026-08-26
6-KForm 6-K2026-08-18
6-KForm 6-K2026-07-31
Insights
Warrants covering 14,681,442 shares at $0.29 expire on October 16, 2028.
· 2028-10-16
Warrants covering 513,850 shares at $0.37 expire on October 10, 2028.
· 2028-10-10
A shelf registration of $10,151,700 is on file and no takedowns have been recorded against it.
F-3 · 2026-07-24
Virax provided a shareholder update on July 16, 2026, detailing fiscal 2026 developments.
6-K · 2026-07-16
Virax's public market valuation was below its audited cash balance as of July 14, 2026.
6-K · 2026-07-14